IPIX OTC
Innovation Pharmaceuticals Inc.
1W: +0.0%
1M: +19900.0%
3M: -33.3%
YTD: -80.0%
1Y: -93.3%
3Y: -98.0%
5Y: -99.9%
$0.00
-0.00 (-80.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$373K
-2172.2% ▼
Operating Income
-$3M
+55.0% ▲
Net Income
-$3M
+55.0% ▲
EPS (Diluted)
$-0.01
+55.0% ▲
EBITDA
-$3M
+58.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $423K | $0 | $18K | $0 |
| YoY Growth | +0.0% | +0.0% | -100.0% | +0.0% | -100.0% |
| Cost of Revenue | $371K | $0 | $378K | $0 | $373K |
| Gross Profit | -$371K | $423K | -$378K | $18K | -$373K |
| Gross Margin | — | 100.0% | — | 100.0% | — |
| R&D Expenses | $4M | $3M | $7M | $5M | $1M |
| SG&A Expenses | $2M | $2M | $2M | $2M | $1M |
| Operating Expenses | $6M | $5M | $9M | $7M | $3M |
| Operating Income | -$6M | -$5M | -$9M | -$7M | -$3M |
| Operating Margin | — | -1095.7% | — | -38450.0% | — |
| Interest Expense | $2M | $260K | $5M | $115K | $57K |
| Income Before Tax | -$9M | -$7M | -$14M | -$7M | -$3M |
| Tax Expense | $390K | $0 | $0 | $0 | $0 |
| Net Income | -$9M | -$7M | -$14M | -$7M | -$3M |
| Net Margin | — | -1571.6% | — | -39116.7% | — |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.04 | $-0.01 | $-0.01 |
| EBITDA | -$6M | -$6M | -$9M | -$7M | -$3M |
| Shares Outstanding | 178M | 237M | 386M | 504M | 506M |